PL2007434T3 - Sposób i układ do określania czy lek będzie skuteczny u pacjenta z chorobą - Google Patents

Sposób i układ do określania czy lek będzie skuteczny u pacjenta z chorobą

Info

Publication number
PL2007434T3
PL2007434T3 PL07754043T PL07754043T PL2007434T3 PL 2007434 T3 PL2007434 T3 PL 2007434T3 PL 07754043 T PL07754043 T PL 07754043T PL 07754043 T PL07754043 T PL 07754043T PL 2007434 T3 PL2007434 T3 PL 2007434T3
Authority
PL
Poland
Prior art keywords
drug
disease
patient
effective
determining whether
Prior art date
Application number
PL07754043T
Other languages
English (en)
Inventor
Heinrich Röder
Maxim Tsypin
Julia Grigorieva
Original Assignee
Biodesix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biodesix Inc filed Critical Biodesix Inc
Publication of PL2007434T3 publication Critical patent/PL2007434T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06F—ELECTRIC DIGITAL DATA PROCESSING
    • G06F18/00—Pattern recognition
    • G06F18/20—Analysing
    • G06F18/21—Design or setup of recognition systems or techniques; Extraction of features in feature space; Blind source separation
    • G06F18/211—Selection of the most significant subset of features
    • G06F18/2115—Selection of the most significant subset of features by evaluating different subsets according to an optimisation criterion, e.g. class separability, forward selection or backward elimination
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06F—ELECTRIC DIGITAL DATA PROCESSING
    • G06F18/00—Pattern recognition
    • G06F18/20—Analysing
    • G06F18/24—Classification techniques
    • G06F18/241—Classification techniques relating to the classification model, e.g. parametric or non-parametric approaches
    • G06F18/2413—Classification techniques relating to the classification model, e.g. parametric or non-parametric approaches based on distances to training or reference patterns
    • G06F18/24147—Distances to closest patterns, e.g. nearest neighbour classification
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06V—IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING
    • G06V20/00—Scenes; Scene-specific elements
    • G06V20/60—Type of objects
    • G06V20/69—Microscopic objects, e.g. biological cells or cellular parts
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06V—IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING
    • G06V2201/00—Indexing scheme relating to image or video recognition or understanding
    • G06V2201/03—Recognition of patterns in medical or anatomical images
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry

Landscapes

  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Theoretical Computer Science (AREA)
  • Data Mining & Analysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Artificial Intelligence (AREA)
  • Evolutionary Computation (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • General Physics & Mathematics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Bioethics (AREA)
  • Software Systems (AREA)
  • Databases & Information Systems (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Multimedia (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
PL07754043T 2006-03-31 2007-03-26 Sposób i układ do określania czy lek będzie skuteczny u pacjenta z chorobą PL2007434T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11/396,328 US7736905B2 (en) 2006-03-31 2006-03-31 Method and system for determining whether a drug will be effective on a patient with a disease
PCT/US2007/007467 WO2007126758A2 (en) 2006-03-31 2007-03-26 Method and system for determining whether a drug will be effective on a patient with a disease
EP07754043.3A EP2007434B1 (en) 2006-03-31 2007-03-26 Method and system for determining whether a drug will be effective on a patient with a disease

Publications (1)

Publication Number Publication Date
PL2007434T3 true PL2007434T3 (pl) 2016-06-30

Family

ID=38559627

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07754043T PL2007434T3 (pl) 2006-03-31 2007-03-26 Sposób i układ do określania czy lek będzie skuteczny u pacjenta z chorobą

Country Status (11)

Country Link
US (6) US7736905B2 (pl)
EP (3) EP2007434B1 (pl)
JP (1) JP4963721B2 (pl)
KR (1) KR101068732B1 (pl)
AU (2) AU2007243644B2 (pl)
CA (1) CA2647871C (pl)
ES (1) ES2564632T3 (pl)
HU (1) HUE027904T2 (pl)
NO (1) NO337745B1 (pl)
PL (1) PL2007434T3 (pl)
WO (1) WO2007126758A2 (pl)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7736905B2 (en) 2006-03-31 2010-06-15 Biodesix, Inc. Method and system for determining whether a drug will be effective on a patient with a disease
US8024282B2 (en) * 2006-03-31 2011-09-20 Biodesix, Inc. Method for reliable classification of samples in clinical diagnostics using an improved method of classification
US7867775B2 (en) 2006-03-31 2011-01-11 Biodesix, Inc. Selection of head and neck cancer patients for treatment with drugs targeting EGFR pathway
US7858389B2 (en) 2006-03-31 2010-12-28 Biodesix, Inc. Selection of non-small-cell lung cancer patients for treatment with monoclonal antibody drugs targeting EGFR pathway
US7906342B2 (en) * 2006-03-31 2011-03-15 Biodesix, Inc. Monitoring treatment of cancer patients with drugs targeting EGFR pathway using mass spectrometry of patient samples
US7858390B2 (en) * 2006-03-31 2010-12-28 Biodesix, Inc. Selection of colorectal cancer patients for treatment with drugs targeting EGFR pathway
US12324657B2 (en) 2007-11-28 2025-06-10 Intervet Inc. System and method for diagnosis of bovine diseases using auscultation analysis
US8042073B1 (en) * 2007-11-28 2011-10-18 Marvell International Ltd. Sorted data outlier identification
US20100017226A1 (en) * 2008-07-18 2010-01-21 Siemens Medical Solutions Usa, Inc. Medical workflow oncology task assistance
US20100082628A1 (en) * 2008-10-01 2010-04-01 Martin Scholz Classifying A Data Item With Respect To A Hierarchy Of Categories
WO2011106084A1 (en) * 2010-02-24 2011-09-01 Biodesix, Inc. Cancer patient selection for administration of therapeutic agents using mass spectral analysis
US20120016598A1 (en) * 2010-05-21 2012-01-19 Bruker Daltonik Gmbh Normalization of mass spectra acquired by mass spectrometric imaging
JP5408107B2 (ja) * 2010-11-10 2014-02-05 株式会社島津製作所 Ｍｓ／ｍｓ型質量分析装置及び同装置用プログラム
JP5556641B2 (ja) * 2010-12-15 2014-07-23 株式会社島津製作所 液体クロマトグラフ質量分析装置
WO2012102829A1 (en) * 2011-01-28 2012-08-02 Biodesix, Inc. Predictive test for selection of metastatic breast cancer patients for hormonal and combination therapy
JP5986646B2 (ja) * 2012-02-07 2016-09-06 マテリアリティクス，エルエルシー 試料を分析する方法およびシステム
US9476871B2 (en) * 2012-05-02 2016-10-25 Diatech Oncology Llc System and method for automated determination of the relative effectiveness of anti-cancer drug candidates
EP2856495A2 (en) 2012-05-29 2015-04-08 Biodesix, Inc. Deep-maldi tof mass spectrometry of complex biological samples, e.g., serum, and uses thereof
SG11201408652SA (en) 2012-06-26 2015-01-29 Biodesix Inc Mass-spectral method for selection, and de-selection, of cancer patients for treatment with immune response generating therapies
AU2013287262A1 (en) 2012-07-05 2015-02-26 Biodesix, Inc. Method for predicting whether a cancer patient will not benefit from platinum-based chemotherapy agents
US9336302B1 (en) 2012-07-20 2016-05-10 Zuci Realty Llc Insight and algorithmic clustering for automated synthesis
US8467988B1 (en) 2013-01-02 2013-06-18 Biodesix, Inc. Method and system for validation of mass spectrometer machine performance
US20150363551A1 (en) * 2013-01-31 2015-12-17 Renaud CEZAR Process for identifying rare events
AU2014215675B2 (en) * 2013-02-06 2018-08-30 Intervet International B.V. System and method for determining antibiotic effectiveness in respiratory diseased using auscultation analysis
WO2014150696A1 (en) 2013-03-15 2014-09-25 Materialytics, LLC Methods and systems for analyzing samples
FR3009088B1 (fr) * 2013-07-24 2016-11-25 Assist Publique - Hopitaux De Marseille Methode de detection de la contamination par un microbe d'un echantillon par analyse de spectres de masse
AU2014318499B2 (en) * 2013-09-16 2019-05-16 Biodesix, Inc Classifier generation method using combination of mini-classifiers with regularization and uses thereof
ES2982998T3 (es) * 2013-09-19 2024-10-21 Oreal Sistemas y métodos para medir y categorizar colores y espectros de superficies
EP3123495B1 (en) * 2014-03-28 2019-11-13 Wisconsin Alumni Research Foundation High mass accuracy filtering for improved spectral matching of high-resolution gas chromatography-mass spectrometry data against unit-resolution reference databases
US9211314B2 (en) 2014-04-04 2015-12-15 Biodesix, Inc. Treatment selection for lung cancer patients using mass spectrum of blood-based sample
WO2015157109A1 (en) * 2014-04-08 2015-10-15 Biodesix, Inc. Egfr and hgf inhibitor therapy for lung cancer
CN105334279B (zh) * 2014-08-14 2017-08-04 大连达硕信息技术有限公司 一种高分辨质谱数据的处理方法
EP3201812B1 (en) 2014-10-02 2021-02-17 Biodesix, Inc. Predictive test for aggressiveness or indolence of prostate cancer from mass spectrometry of blood-based sample
US11594403B1 (en) 2014-12-03 2023-02-28 Biodesix Inc. Predictive test for prognosis of myelodysplastic syndrome patients using mass spectrometry of blood-based sample
TW201621315A (zh) 2014-12-03 2016-06-16 拜歐迪希克斯公司 使用ｍａｌｄｉ－ｔｏｆ質譜分析以早期偵測高風險群中之肝細胞癌
GB201502447D0 (en) * 2015-02-13 2015-04-01 Univ Liverpool Method and apparatus for sample analysis
WO2016175990A1 (en) 2015-04-30 2016-11-03 Biodesix, Inc. Bagged filtering method for selection and deselection of features for classification
CN112710723B (zh) 2015-07-13 2024-11-12 佰欧迪塞克斯公司 受益于pd-1抗体药物的肺癌患者的预测性测试和分类器开发方法
WO2017136139A1 (en) 2016-02-01 2017-08-10 Biodesix, Inc. Predictive test for melanoma patient benefit from interleukin-2 (il2) therapy
US11621057B2 (en) 2016-04-08 2023-04-04 Biodesix, Inc. Classifier generation methods and predictive test for ovarian cancer patient prognosis under platinum chemotherapy
US10636636B2 (en) * 2016-05-23 2020-04-28 Thermo Finnigan Llc Systems and methods for sample comparison and classification
US10605842B2 (en) * 2016-06-21 2020-03-31 International Business Machines Corporation Noise spectrum analysis for electronic device
US11205103B2 (en) 2016-12-09 2021-12-21 The Research Foundation for the State University Semisupervised autoencoder for sentiment analysis
EP3566054A4 (en) * 2017-01-05 2020-12-09 Biodesix, Inc. PROCESS FOR IDENTIFYING CANCER PATIENTS LIKELY TO BENEFIT FROM IMMUNOTHERAPY FOR LASTING SUSTAINABLE SUB-GROUPS OF PATIENTS WHO HAVE A BAD PROGNOSIS GENERALLY
US20190034047A1 (en) * 2017-07-31 2019-01-31 Wisconsin Alumni Research Foundation Web-Based Data Upload and Visualization Platform Enabling Creation of Code-Free Exploration of MS-Based Omics Data
CN109507347B (zh) * 2017-09-14 2021-01-29 湖南中烟工业有限责任公司 一种色谱峰选择方法
EP3724885A2 (en) 2017-12-15 2020-10-21 Iovance Biotherapeutics, Inc. Systems and methods for determining the beneficial administration of tumor infiltrating lymphocytes, and methods of use thereof and beneficial administration of tumor infiltrating lymphocytes, and methods of use thereof
US12094587B2 (en) 2018-03-29 2024-09-17 Biodesix, Inc. Apparatus and method for identification of primary immune resistance in cancer patients
JP6915604B2 (ja) * 2018-11-28 2021-08-04 横河電機株式会社 装置、方法およびプログラム
US11386408B2 (en) * 2019-11-01 2022-07-12 Intuit Inc. System and method for nearest neighbor-based bank account number validation
CN110988205B (zh) * 2019-11-26 2021-08-10 厦门历思科技服务有限公司 人体摄入物质及摄入次数的新型检测方法
KR20230054473A (ko) * 2020-09-04 2023-04-24 주식회사 아데랑스 담즙산류, 스테롤류 및 호르몬류의 분석 방법 및 분석 시스템
WO2022084993A1 (en) * 2020-10-19 2022-04-28 B. G. Negev Technologies And Applications Ltd., At Ben-Gurion University Rapid and direct identification and determination of urine bacterial susceptibility to antibiotics
US11476003B2 (en) 2020-12-15 2022-10-18 Biodesix, Inc. Method for predicting risk of unfavorable outcomes, e.g., in COVID-19 hospitalization, from clinical characteristics and basic laboratory findings
CN113449804B (zh) * 2021-07-09 2023-03-10 曲阜师范大学 血液类别的确定方法及相关设备
CN119064294B (zh) * 2024-11-04 2025-02-18 陕西省核工业二一五医院 一种面向临床药学的血药浓度检测方法、设备及系统

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4346998A (en) 1976-11-15 1982-08-31 Hoffmann-La Roche Inc. Background corrector for spectrochemical analyses of biological samples
US4802102A (en) 1987-07-15 1989-01-31 Hewlett-Packard Company Baseline correction for chromatography
US5291426A (en) 1991-02-27 1994-03-01 The Perkin-Elmer Corporation Method of correcting spectral data for background
ES2070739B1 (es) 1993-04-30 1997-06-01 Alcatel Standard Electrica Dispositivo de conversion de interfaces.
US6017693A (en) 1994-03-14 2000-01-25 University Of Washington Identification of nucleotides, amino acids, or carbohydrates by mass spectrometry
US5672869A (en) 1996-04-03 1997-09-30 Eastman Kodak Company Noise and background reduction method for component detection in chromatography/spectrometry
CA2237255C (en) 1997-05-30 2007-07-24 Mds Inc. Method for improving signal-to-noise for multiply charged ions
US6147344A (en) 1998-10-15 2000-11-14 Neogenesis, Inc Method for identifying compounds in a chemical mixture
US6253162B1 (en) 1999-04-07 2001-06-26 Battelle Memorial Institute Method of identifying features in indexed data
ATE406627T1 (de) 2000-06-19 2008-09-15 Correlogic Systems Inc Heuristisches klassifikationsverfahren
EP1324690A1 (en) 2000-07-13 2003-07-09 Medi-Physics, Inc. DIAGNOSTIC PROCEDURES USING ?129 XE SPECTROSCOPY CHARACTERISTIC CHEMICAL SHIFT TO DETECT PATHOLOGY i IN VIVO /i
EP1386275A2 (en) 2000-07-18 2004-02-04 Correlogic Systems, Inc. A process for discriminating between biological states based on hidden patterns from biological data
EP1337845B1 (en) 2000-11-16 2012-01-04 Bio-Rad Laboratories, Inc. Method for analyzing mass spectra
US20020119490A1 (en) 2000-12-26 2002-08-29 Aebersold Ruedi H. Methods for rapid and quantitative proteome analysis
US20020115056A1 (en) 2000-12-26 2002-08-22 Goodlett David R. Rapid and quantitative proteome analysis and related methods
US6829539B2 (en) 2001-04-13 2004-12-07 The Institute For Systems Biology Methods for quantification and de novo polypeptide sequencing by mass spectrometry
US6849121B1 (en) 2001-04-24 2005-02-01 The United States Of America As Represented By The Secretary Of The Air Force Growth of uniform crystals
US7314717B2 (en) 2001-04-30 2008-01-01 Nanogen Inc. Biopolymer marker indicative of disease state having a molecular weight of 1562 daltons
US7113896B2 (en) 2001-05-11 2006-09-26 Zhen Zhang System and methods for processing biological expression data
US6675106B1 (en) 2001-06-01 2004-01-06 Sandia Corporation Method of multivariate spectral analysis
US7112408B2 (en) 2001-06-08 2006-09-26 The Brigham And Women's Hospital, Inc. Detection of ovarian cancer based upon alpha-haptoglobin levels
US20030068825A1 (en) 2001-07-13 2003-04-10 Washburn Michael P. System and method of determining proteomic differences
WO2003017177A2 (en) 2001-08-13 2003-02-27 Beyong Genomics, Inc. Method and system for profiling biological systems
AU2002323683A1 (en) 2002-03-01 2003-09-16 Applera Corporation Method for protein identification using mass spectrometry data
US7016884B2 (en) 2002-06-27 2006-03-21 Microsoft Corporation Probability estimate for K-nearest neighbor
US6698040B1 (en) * 2002-07-19 2004-03-02 Oscar Acevedo Retractable bed
NZ562192A (en) * 2002-08-06 2009-07-31 Ciphergen Biosystems Inc Use of biomarkers for detecting ovarian cancer
US20040102906A1 (en) 2002-08-23 2004-05-27 Efeckta Technologies Corporation Image processing of mass spectrometry data for using at multiple resolutions
JP2006522340A (ja) 2003-04-02 2006-09-28 メルク　エンド　カムパニー　インコーポレーテッド 質量分析データの分析法
EP1636380A2 (en) * 2003-05-30 2006-03-22 Genomic Health, Inc. Gene expression markers for response to egfr inhibitor drugs
US20050267689A1 (en) 2003-07-07 2005-12-01 Maxim Tsypin Method to automatically identify peak and monoisotopic peaks in mass spectral data for biomolecular applications
WO2005010492A2 (en) * 2003-07-17 2005-02-03 Yale University Classification of disease states using mass spectrometry data
AU2004261222A1 (en) 2003-08-01 2005-02-10 Correlogic Systems, Inc. Multiple high-resolution serum proteomic features for ovarian cancer detection
EP1709442A4 (en) 2003-12-11 2010-01-20 Correlogic Systems Inc METHOD FOR DIAGNOSING BIOLOGICAL CONDITIONS BY USING A CENTRALIZED ADAPTIVE MODEL AND SAMPLE PREPARATION
CA2561535A1 (en) * 2004-03-30 2005-10-20 Eastern Virginia Medical School Lung cancer biomarkers
CN101501211A (zh) * 2004-03-31 2009-08-05 综合医院公司 测定癌症对表皮生长因子受体靶向性治疗反应性的方法
US20060029574A1 (en) 2004-08-06 2006-02-09 Board Of Regents, The University Of Texas System Biomarkers for diagnosis, prognosis, monitoring, and treatment decisions for drug resistance and sensitivity
US7867775B2 (en) 2006-03-31 2011-01-11 Biodesix, Inc. Selection of head and neck cancer patients for treatment with drugs targeting EGFR pathway
US7858389B2 (en) 2006-03-31 2010-12-28 Biodesix, Inc. Selection of non-small-cell lung cancer patients for treatment with monoclonal antibody drugs targeting EGFR pathway
US7736905B2 (en) 2006-03-31 2010-06-15 Biodesix, Inc. Method and system for determining whether a drug will be effective on a patient with a disease
US7858390B2 (en) 2006-03-31 2010-12-28 Biodesix, Inc. Selection of colorectal cancer patients for treatment with drugs targeting EGFR pathway

Also Published As

Publication number Publication date
NO337745B1 (no) 2016-06-13
HUE027904T2 (en) 2016-11-28
EP2007434A2 (en) 2008-12-31
WO2007126758A2 (en) 2007-11-08
AU2010201206B2 (en) 2012-03-08
NO20084615L (no) 2008-12-19
KR101068732B1 (ko) 2011-09-28
EP2007434B1 (en) 2016-02-17
HK1126416A1 (zh) 2009-09-04
JP2009532673A (ja) 2009-09-10
CA2647871C (en) 2014-03-11
US20100174492A1 (en) 2010-07-08
EP2251044A1 (en) 2010-11-17
US20120089341A1 (en) 2012-04-12
US20120191370A1 (en) 2012-07-26
AU2010201206A1 (en) 2010-04-15
EP2241335B1 (en) 2019-02-27
AU2007243644B2 (en) 2010-05-20
CA2647871A1 (en) 2007-11-08
US20070231921A1 (en) 2007-10-04
US9152758B2 (en) 2015-10-06
AU2007243644A1 (en) 2007-11-08
JP4963721B2 (ja) 2012-06-27
US7879620B2 (en) 2011-02-01
US8097469B2 (en) 2012-01-17
ES2564632T3 (es) 2016-03-28
US20100305868A1 (en) 2010-12-02
WO2007126758A3 (en) 2008-01-10
US9824182B2 (en) 2017-11-21
EP2007434A4 (en) 2009-09-09
US20100204061A1 (en) 2010-08-12
KR20080108599A (ko) 2008-12-15
EP2241335A1 (en) 2010-10-20
US7736905B2 (en) 2010-06-15

Similar Documents

Publication Publication Date Title
PL2007434T3 (pl) Sposób i układ do określania czy lek będzie skuteczny u pacjenta z chorobą
IL266164B (en) A system and method for determining a personalized medical intervention for a disease stage
IL182332A0 (en) System and method for assessing a patient condition
EP2043522A4 (en) SYSTEM AND METHOD FOR NON-INVASIVE MEDICAL SENSOR
EP2011046A4 (en) SYSTEMS AND METHOD FOR THE ADMINISTRATION AND MANAGEMENT OF MEDICAMENTS
GB2451364B (en) Vaginal drug delivery system and method
GB0910232D0 (en) System and method for in-situ mental health monitoring and therapy administration
EP2073690A4 (en) SYSTEM AND METHOD FOR PROVIDING HEALTH RATING FOR A PATIENT
EP2080169A4 (en) SYSTEM AND METHOD FOR SEGMENTING A REGION IN A MEDICAL IMAGE
PL2330527T3 (pl) Układ i sposób określania informacji dotyczących podawania leków
GB2435625B (en) A Reductant storage sensing system and method
EP2010246A4 (en) DEVICE AND METHOD FOR DRUG DELIVERY
EP1903936A4 (en) THERAPEUTIC OBSERVANCE SYSTEM AND ASSOCIATED METHODS
EP2041524A4 (en) ACQUISITION OF MEDICAL DATA AND PATIENT SUPPORT SYSTEM AND METHOD
EP2040171A4 (en) DEVICE AND METHOD FOR COMPUTER SYSTEM MANAGEMENT
PL2035989T3 (pl) System i sposób gromadzenia informacji o pacjencie, na podstawie których można wyznaczyć przebieg leczenia cukrzycy
GB0914354D0 (en) Methods and systems for providing clinical documentation for a patient lifetime in a single interface
EP2043617A4 (en) SYSTEM FOR MANAGING THERAPY AND MONITORING SUBSTANCE TO BE ANALYZED AND METHODS THEREFOR
EP1721156A4 (en) SYSTEMS AND METHODS OF DISEASE DIAGNOSIS
IL196694A (en) Iterative methods for dose reduction and image enhancement in tomography
PL2073864T5 (pl) Urządzenie i sposób odzyskiwania krwi
EP2057591A4 (en) SYSTEM AND METHOD FOR SUPPORTING MEDICAL EXAMINATIONS
GB0810016D0 (en) Method and system for transdermal drug delivery
GB0901245D0 (en) System managing program, system managing device and system managing method
EP1976426A4 (en) SYSTEM AND METHODS FOR MEDICAL DIAGNOSIS